Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Marina Petrova
Marina Petrova
London +44 20 7067 2284 mpetrova@cov.com Download V-card

Marina Petrova is a corporate associate based in Covington’s London office.  Ms. Petrova advises clients on a broad range of corporate matters, including venture capital financings, M&A transactions and international securities offerings.

  • Advised Mission Therapeutics Limited, a UK-based drug discovery and development company, on a venture capital financing of up to £60 million. The financing was jointly led by Imperial Innovations Businesses LLP and new investor Woodford Patient Capital Trust Plc, with follow-on investment from existing shareholders Sofinnova Partners, SR One, Roche Venture Fund and Pfizer Venture Investments.
  • Advised the investment arm of a multinational telecommunications company in relation to a venture capital investment in a UK e-commerce start-up.
  • Advised Oxford BioMedica plc, a gene based biopharmaceutical company, in relation to a $50 million secured loan facility.
  • Advised Vernalis plc, a UK-based development stage pharmaceutical company, in its acquisition of the U.S. rights to MOXATAG® (amoxicillin extended-release tablets) from Pragma Pharmaceuticals, LLC.
  • Advised a UK-based online retailer in its acquisition of four specialist online retailers based in the U.S. and the UK.
  • Advised a U.S.-based life sciences company in relation to the global merger control review of its $13.6 billion acquisition by another U.S.-based life sciences company.    
  • Advised the joint book runners in relation to the £121 million London Stock Exchange IPO and Rule144A placing of a leading specialist retailer of video games.
  • Acted as international transaction counsel in the U.S.$110 million Egyptian Exchange IPO and Rule144A placing of an Egyptian cement producer.
  • Advised a Chinese service provider in the oil and gas industry on its international placing of shares to cornerstone investors under Regulation S in conjunction with a Hong Kong IPO.
  • Advised a European bank about its role as Share Exchange Agent in a $9 billion SEC-registered exchange offer and an associated listing in New York, London and Athens.

Previous Experience

  • Corporate associate at an international law firm.
  • Legal intern at the Berkman Center for Internet and Society, Harvard Law School.